Pathfinder Cell Therapy

(OTC) PFND

Current Price$0.00

Market Cap$700

Since IPO (2011)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Pathfinder Cell Therapy Financials at a Glance

Market Cap

$700

Revenue (TTM)

$0.00

Net Income (TTM)

$1.39M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-3.23 (Low)

Dividend

$0.00

Beta (Volatility)

-3.23 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

-3.23 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PFND News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pathfinder Cell Therapy

Industry

Biotechnology

Sector

Health Care

Headquarters

Cambridge, MA 02138, US

PFND Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

19%

Return on Assets

-16%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$700.00

Shares Outstanding

667.16M

Volume

1.00K

Avg. Volume

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.12M

EBITDA

$1.12M

Operating Cash Flow

$963.00K

Capital Expenditure

$0.00

Free Cash Flow

$963.00K

Cash & ST Invst.

$26.00K

Total Debt

$4.98M

Pathfinder Cell Therapy Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2015YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$700.00

N/A

Market Cap/Employee

$700.00

N/A

Employees

N/A

Net Income

$369.00K

-3.9%

EBITDA

$208.00K

+1.9%

Quarterly Fundamentals

Name

Q3 2015YOY CHG

Net Cash

$5.41M

-13.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$5.41M

+12.7%

Return on Assets

-15.75%

N/A

Return on Invested Capital

18.83%

N/A

Free Cash Flow

$178.00K

+21.9%

Operating Cash Flow

$178.00K

+21.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BNGIBangi Inc.

BNGIBangi Inc.$0.00+0.00%

RGBPRegen BioPharma, Inc.

RGBPRegen BioPharma, Inc.$0.00+16.67%

MCETMultiCell Technologies, Inc.

MCETMultiCell Technologies, Inc.$0.00+0.00%

BPTSYBiophytis S.A.

BPTSYBiophytis S.A.$0.25+0.00%

CBDGTHC Farmaceuticals, Inc.

CBDGTHC Farmaceuticals, Inc.$0.02+0.00%

VIRXViracta Therapeutics, Inc.

VIRXViracta Therapeutics, Inc.$0.01+0.00%

TSOITherapeutic Solutions International, Inc.

TSOITherapeutic Solutions International, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

NIONio

NIONio$5.91-0.08%

Questions About PFND

What is the current price of Pathfinder Cell Therapy?

Pathfinder Cell Therapy is trading at N/A per share.

What is the 52-week range for Pathfinder Cell Therapy?

Over the past 52 weeks, Pathfinder Cell Therapy has traded between N/A and N/A.

How much debt does Pathfinder Cell Therapy have?

Pathfinder Cell Therapy total debt is unavailable.

How much cash does Pathfinder Cell Therapy have on hand?

Pathfinder Cell Therapy does not have cash on hand data available.

What is Pathfinder Cell Therapy’s dividend yield?

Pathfinder Cell Therapy does not currently have a dividend yield.

Pathfinder Cell Therapy

Pathfinder Cell Therapy Financials at a Glance

PFND News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pathfinder Cell Therapy

PFND Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pathfinder Cell Therapy Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PFND

What is the current price of Pathfinder Cell Therapy?

What is the 52-week range for Pathfinder Cell Therapy?

How much debt does Pathfinder Cell Therapy have?

How much cash does Pathfinder Cell Therapy have on hand?

What is Pathfinder Cell Therapy’s dividend yield?

Premium Investing Services